Allient (ALNT) Competitors $39.33 +0.05 (+0.11%) As of 10:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALNT vs. TXG, TRNS, EYPT, LAB, CTKB, AEHR, SENS, QSI, QTRX, and MASSShould you be buying Allient stock or one of its competitors? The main competitors of Allient include 10x Genomics (TXG), Transcat (TRNS), Eyepoint Pharmaceuticals (EYPT), Standard BioTools (LAB), Cytek Biosciences (CTKB), Aehr Test Systems (AEHR), Senseonics (SENS), Quantum-Si (QSI), Quanterix (QTRX), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Allient vs. Its Competitors 10x Genomics Transcat Eyepoint Pharmaceuticals Standard BioTools Cytek Biosciences Aehr Test Systems Senseonics Quantum-Si Quanterix 908 Devices Allient (NASDAQ:ALNT) and 10x Genomics (NASDAQ:TXG) are both small-cap measuring and control equipment companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations. Do analysts prefer ALNT or TXG? Allient presently has a consensus target price of $31.00, suggesting a potential downside of 21.17%. 10x Genomics has a consensus target price of $13.23, suggesting a potential downside of 2.52%. Given 10x Genomics' higher probable upside, analysts clearly believe 10x Genomics is more favorable than Allient.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Allient 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.5010x Genomics 1 Sell rating(s) 5 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.42 Does the media prefer ALNT or TXG? In the previous week, 10x Genomics had 5 more articles in the media than Allient. MarketBeat recorded 10 mentions for 10x Genomics and 5 mentions for Allient. 10x Genomics' average media sentiment score of 1.04 beat Allient's score of 0.47 indicating that 10x Genomics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Allient 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral 10x Genomics 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in ALNT or TXG? 61.6% of Allient shares are held by institutional investors. Comparatively, 84.7% of 10x Genomics shares are held by institutional investors. 15.6% of Allient shares are held by insiders. Comparatively, 9.4% of 10x Genomics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, ALNT or TXG? Allient has higher earnings, but lower revenue than 10x Genomics. 10x Genomics is trading at a lower price-to-earnings ratio than Allient, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAllient$529.97M1.26$13.17M$0.5966.6510x Genomics$610.78M2.74-$182.63M-$1.30-10.44 Which has more volatility & risk, ALNT or TXG? Allient has a beta of 1.51, suggesting that its share price is 51% more volatile than the S&P 500. Comparatively, 10x Genomics has a beta of 2.03, suggesting that its share price is 103% more volatile than the S&P 500. Is ALNT or TXG more profitable? Allient has a net margin of 1.90% compared to 10x Genomics' net margin of -25.14%. Allient's return on equity of 8.45% beat 10x Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Allient1.90% 8.45% 3.86% 10x Genomics -25.14%-23.22%-18.02% SummaryAllient and 10x Genomics tied by winning 8 of the 16 factors compared between the two stocks. Get Allient News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ALNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALNT vs. The Competition Export to ExcelMetricAllientELEC IndustryComputer SectorNASDAQ ExchangeMarket Cap$667.89M$5.36B$28.90B$9.50BDividend Yield0.30%2.77%3.01%3.99%P/E Ratio66.8731.0634.0319.97Price / Sales1.262.241,734.59101.58Price / Cash13.2423.5138.6558.97Price / Book2.502.297.815.89Net Income$13.17M$171.53M$781.95M$258.50M7 Day Performance-1.24%1.94%0.91%2.07%1 Month Performance12.33%3.16%7.46%12.39%1 Year Performance40.70%-1.02%53,001.55%19.25% Allient Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALNTAllient2.1913 of 5 stars$39.33+0.1%$31.00-21.2%+44.0%$667.89M$529.97M66.872,525News CoverageTXG10x Genomics4.1448 of 5 stars$12.47-2.6%$14.13+13.3%-27.6%$1.54B$624.66M-9.591,240TRNSTranscat2.8522 of 5 stars$86.45-0.2%$112.20+29.8%-40.6%$805.71M$278.42M55.421,245EYPTEyepoint Pharmaceuticals1.5981 of 5 stars$10.17-1.8%$25.67+152.4%+14.5%$699.81M$56.04M-4.22120LABStandard BioTools3.6297 of 5 stars$1.25-5.3%$2.50+100.0%-34.7%$474.78M$169.69M-3.57620Upcoming EarningsGap DownCTKBCytek Biosciences3.2366 of 5 stars$3.35-2.9%$5.60+67.2%-47.0%$424.31M$197.05M-37.22500News CoveragePositive NewsGap DownAEHRAehr Test Systems1.9578 of 5 stars$13.86-1.8%$25.00+80.4%+25.1%$412.61M$58.97M-106.6190Insider TradeSENSSenseonics2.1649 of 5 stars$0.49-0.8%$1.70+244.9%+24.8%$322.46M$23.68M-3.7990Positive NewsQSIQuantum-Si2.3628 of 5 stars$1.73flat$3.48+100.9%+90.4%$317.45M$3.44M-2.54150Positive NewsGap UpQTRXQuanterix2.728 of 5 stars$6.05+2.7%$13.50+123.1%-64.1%$302.20M$137.42M-4.65460Positive NewsMASS908 Devices1.3917 of 5 stars$6.72-3.2%$5.33-20.6%+37.2%$240.98M$59.63M-12.4460News CoveragePositive News Related Companies and Tools Related Companies 10x Genomics Alternatives Transcat Alternatives Eyepoint Pharmaceuticals Alternatives Standard BioTools Alternatives Cytek Biosciences Alternatives Aehr Test Systems Alternatives Senseonics Alternatives Quantum-Si Alternatives Quanterix Alternatives 908 Devices Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALNT) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allient Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Allient With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALNT Stock Alerts